Current status and research progress of surgical<b>-</b>induced liver volume hyperplasia_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

SU Yu ¹ , WU Hong ² ,  LIU Chang ^1,3

1. Division of Liver, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. Liver Transplant Center, Organ Transplant Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
3. Department of Minimal Invasive Surgery, Shangjin Nanfu Hospital, Chengdu 610037, P. R. China;

Corresponding author：

LIU Chang, Email: drliuchang@wchscu.cn

Keywords：

liver; volume hyperplasia; hepatic blood inflow

DOI：

10.7507/1007-9424.202109066

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To review the current status and progress of surgical methods for inducing hepatic volume hyperplasia. Method The procedures inducing liver volume regeneration in clinical practice, including portal vein embolization, liver venous deprivation, Yttrium-90 selective internal radiation therapy, and associating liver partition and portal vein ligation for staged hepatectomy were reviewed and summarized. Results All kinds of surgical methods to induce liver volume hyperplasia could effectively stimulate the increase in liver volume, which could provide more surgical opportunities for patients with too small future liver remnant, but there were differences in the degree of trauma, proliferation efficiency and popularization and acceptance. Conclusions All kinds of operations provide new hope for patients with too little residual liver volume after operation, and have good application scenarios. However, at present, there is no unified opinion on the comparison between the advantages and disadvantages of each operation and the best indication, which needs further study.

Citation： SU Yu, WU Hong, LIU Chang. Current status and research progress of surgical-induced liver volume hyperplasia. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2024, 31(1): 103-108. doi: 10.7507/1007-9424.202109066 Copy

1.	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
2.	中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版). 中华肝脏病杂志, 2022, 30(4): 367-388.
3.	Memeo R, Conticchio M, Deshayes E, et al. Optimization of the future remnant liver: review of the current strategies in Europe. Hepatobiliary Surg Nutr, 2021, 10(3): 350-363.
4.	Dixon M, Cruz J, Sarwani N, et al. The future liver remnant : definition, evaluation, and management. Am Surg, 2021, 87(2): 276-286.
5.	Zhao HT, Cai JQ. Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. World J Gastroenterol, 2021, 27(47): 8069-8080.
6.	孙惠川, 沈英皓, 李小龙. 肝脏储备功能与肝癌术式选择. 中国实用外科杂志, 2018, 38(4): 473-476.
7.	Saxena R, Theise ND, Crawford JM. Microanatomy of the human liver-exploring the hidden interfaces. Hepatology, 1999, 30(6): 1339-1346.
8.	Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol, 2021, 18(1): 40-55.
9.	Preziosi ME, Monga SP. Update on the mechanisms of liver regeneration. Semin Liver Dis, 2017, 37(2): 141-151.
10.	包胜娴. 原发性肝癌ALPPS- Ⅰ围术期肝脏血流动力学变化及其与剩余肝体积再生关系初步研究 . 南宁: 广西医科大学, 2023.
11.	Kawaguchi Y, Lillemoe HA, Vauthey JN. Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy. J Surg Oncol, 2019, 119(5): 594-603.
12.	林伟鸿, 李凯. 肝切除术前肝脏储备功能评估方式的新进展. 中华外科杂志, 2021, 59(5): 392-396.
13.	王荣福, 庞小溪, 刘敏, 等. ^99mTc-GSA肝受体显像在肝功能评估临床研究应用及进展. 世界华人消化杂志, 2017, 25(21): 1903-1909.
14.	Gavriilidis P, Edwin B, Pelanis E, et al. Navigated liver surgery: State of the art and future perspectives. Hepatobiliary Pancreat Dis Int, 2022, 21(3): 226-233.
15.	Kim D, Cornman-Homonoff J, Madoff DC. Preparing for liver surgery with “Alphabet Soup”: PVE, ALPPS, TAE-PVE, LVD and RL. Hepatobiliary Surg Nutr, 2020, 9(2): 136-151.
16.	陈乾, 林慧敏, 严福华. 磁共振成像评估肝功能储备的研究进展. 诊断学理论与实践, 2023, 22(2): 190-196.
17.	Poetter-Lang S, Bastati N, Messner A, et al. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom Radiol (NY), 2020, 45(11): 3532-3544.
18.	Rous P, Larimore LD. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med, 1920, 31(5): 609-632.
19.	Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg, 1986, 10(5): 803-808.
20.	Vaupel P, Multhoff G. Blood supply and oxygenation status of the liver: from physiology to malignancy. Adv Exp Med Biol, 2022, 1395: 263-267.
21.	郑本波, 黄文. 术前经皮选择性门静脉栓塞术在肝胆肿瘤的应用体会. 肝胆外科杂志, 2021, 29(1): 46-48.
22.	Isfordink CJ, Samim M, Braat MNGJA, et al. Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant: A systematic review and meta-analysis. Surg Oncol, 2017, 26(3): 257-267.
23.	Brüning R, Schneider M, Tiede M, et al. Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales. CVIR Endovasc, 2021, 4(1): 41.
24.	Palavecino M, Chun YS, Madoff DC, et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery, 2009, 145(4): 399-405.
25.	Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg, 2000, 232(5): 665-672.
26.	Wakabayashi H, Ishimura K, Okano K, et al. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer, 2001, 92(9): 2384-2390.
27.	Glantzounis GK, Tokidis E, Basourakos SP, et al. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol, 2017, 43(1): 32-41.
28.	赵文超, 吴印涛, 杨英祥, 等. 肝动脉插管化疗栓塞联合选择性门静脉栓塞后手术切除治疗大肝癌的安全性和有效性观察. 中华肝胆外科杂志, 2021, 27(3): 164-168.
29.	Kudo M, Ueshima K, Chan S, et al. Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study. Cancers (Basel), 2019, 11(8): 1084.
30.	徐彬, 李小龙, 朱小东, 等. 在接受仑伐替尼联合PD-1抗体治疗的不可切除肝细胞癌患者肝切除术前行门静脉栓塞术的研究. 中华肝胆外科杂志, 2022, 28(1): 21-27.
31.	Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg, 2009, 249(4): 608-616.
32.	Munene G, Parker RD, Larrigan J, et al. Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases. World J Surg Oncol, 2013, 11: 134.
33.	Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol, 2016, 26(12): 4259-4267.
34.	刘畅, 张晓赟, 金谌, 等. 肝静脉系统栓堵术在第二阶段根治性肝癌切除术中的应用. 中国普外基础与临床杂志, 2019, 26(7): 841-846.
35.	王明宇, 梁英健, 尹兵, 等. 肝静脉剥夺术—残余肝脏不足时手术新思路. 中国实用外科杂志, 2020, 40(1): 102-105.
36.	Schadde E, Guiu B, Deal R, et al. Simultaneous hepatic and portal vein ligation induces rapid liver hypertrophy: A study in pigs. Surgery, 2019, 165(3): 525-533.
37.	Ko GY, Hwang S, Sung KB, et al. Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant. J Hepatobiliary Pancreat Sci, 2010, 17(4): 410-412.
38.	侯昌龙, 王继洲, 宋瑞鹏, 等. 术前肝静脉剥夺术同期联合精准肝动脉化疗栓塞在原发性大肝癌二期切除中应用价值研究. 中国实用外科杂志, 2022, 42(6): 667-671.
39.	Cassese G, Troisi RI, Khayat S, et al. Liver venous deprivation versus associating liver partition and portal vein ligation for staged hepatectomy for colo-rectal liver metastases: a comparison of early and late kinetic growth rates, and perioperative and oncological outcomes. Surg Oncol, 2022, 43: 101812.
40.	Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy? A retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
41.	Girard E, Trilling B, Chirica M. Comment on: liver venous deprivation (LVD) or associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)? A retrospective multicentric study. Hepatobiliary Surg Nutr, 2021, 10(5): 675-677.
42.	Guiu B, Quenet F, Panaro F, et al. Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes. Hepatobiliary Surg Nutr, 2020, 9(5): 564-576.
43.	Gavriilidis P, Marangoni G, Ahmad J, et al. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis. Hepatobiliary Pancreat Dis Int, 2023, 22(3): 221-227.
44.	Panaro F, Giannone F, Riviere B, et al. Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr, 2019, 8(4): 329-337.
45.	Böning G, Fehrenbach U, Auer TA, et al. Liver venous deprivation (LVD) versus portal vein embolization (PVE) alone prior to extended hepatectomy: A matched pair analysis. Cardiovasc Intervent Radiol, 2022, 45(7): 950-957.
46.	高洁, 刘晓明, 周文华, 等. ⁹⁰Y微球的研发现状与应用研究. 同位素, 2022, 35(3): 189-199.
47.	Jakobs TF, Saleem S, Atassi B, et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with ⁹⁰Yttrium microspheres. Dig Dis Sci, 2008, 53(9): 2556-2563.
48.	Teo JY, Allen JC, Ng DC, et al. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with ⁹⁰Y. HPB (Oxford), 2016, 18(1): 7-12.
49.	Garlipp B, de Baere T, Damm R, et al. Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. Hepatology, 2014, 59(5): 1864-1873.
50.	Teo JY, Goh BK. Contra-lateral liver lobe hypertrophy after unilobar ⁹⁰Y radioembolization: an alternative to portal vein embolization? World J Gastroenterol, 2015, 21(11): 3170-3173.
51.	Birgin E, Rasbach E, Seyfried S, et al. Contralateral liver hypertrophy and oncological outcome following radioembolization with ⁹⁰Y-microspheres: A systematic review. Cancers (Basel), 2020, 12(2): 294.
52.	Najafi A, Binkert CA. Transarterial radioembolization to impact liver volumetry: when and how. Cardiovasc Intervent Radiol, 2022, 45(11): 1646-1650.
53.	Garlipp B, Gibbs P, Van Hazel GA, et al. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial. Br J Surg, 2019, 106(13): 1837-1846.
54.	Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg, 2012, 255(3): 405-414.
55.	周俭, 王征, 孙健, 等. 联合肝脏离断和门静脉结扎的二步肝切除术. 中华消化外科杂志, 2013, 12(7): 485-489.
56.	李世思, 郭志唐, 陈章彬, 等. ALPPS治疗肝脏肿瘤的研究进展. 肝胆胰外科杂志, 2021, 33(4): 253-257.
57.	刘允怡, 刘晓欣. 对“联合肝脏离断和门静脉结扎的二步肝切除术”的述评. 中华消化外科杂志, 2013, 12(7): 481-484.
58.	杨奎, 陈拥军. 联合肝脏离断和门静脉结扎二步肝切除术的热点与争议. 中华普通外科杂志, 2018, 33(2): 172-175.
59.	Sparrelid E, Hasselgren K, Røsok BI, et al. How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility. Hepatobiliary Surg Nutr, 2021, 10(1): 1-8.
60.	王征, 樊嘉, 周俭. ALPPS在肝脏外科的应用前景. 肝胆外科杂志, 2015, 23(1): 1-2.
61.	蔡涵晖, 胡智明, 杨鸿国. 门静脉栓塞术在计划性肝切除中的临床应用. 中华普通外科杂志, 2019, 34(2): 184-186.
62.	彭驰涵, 李川, 文天夫, 等. 原发性肝癌行ALPPS的适应证与禁忌证初探(附15例报道). 中国普外基础与临床杂志, 2015, 22(10): 1183-1186.
63.	陈伟, 梁力建. 联合肝脏离断和门静脉结扎的二步肝切除术在肝脏肿瘤治疗中的应用. 中华普通外科学文献(电子版), 2014, 8(3): 237-240.
64.	文天夫. ALPPS在肝细胞癌治疗中的地位. 中国普外基础与临床杂志, 2016, 23(1): 1-4.
65.	Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg, 2015, 261(4): e90-e92.
66.	Khajeh E, Ramouz A, Dooghaie Moghadam A, et al. Efficacy of technical modifications to the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure: A systematic review and meta-analysis. Ann Surg Open, 2022, 3(4): e221.
67.	闫加艳, 杨欣荣, 周俭. 联合肝脏分隔和门静脉结扎的二步肝切除术临床与基础研究进展. 中国普通外科杂志, 2023, 32(7): 967-976.
68.	Gringeri E, Boetto R, D’Amico FE, et al. Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach. Ann Surg, 2015, 261(2): e42-e43.
69.	首志雄, 郑达武, 梁泳荣, 等. 腹腔镜辅助微波消融后行ALPPS治疗原发性肝癌的临床疗效观察. 中国普外基础与临床杂志, 2023, 30(8): 939-943.
70.	徐邦浩, 蓝祝晶, 朱海, 等. 联合肝实质分隔和门静脉结扎的二步肝切除术式演变进展. 中国普外基础与临床杂志, 2023, 30(7): 870-876.
71.	周承汇, 罗慧, 李嘉荣, 等. 腹腔镜辅助与开腹ALPPS治疗肝癌的近期疗效比较. 中国普通外科杂志, 2019, 28(3): 366-370.

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
2. 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版). 中华肝脏病杂志, 2022, 30(4): 367-388.
3. Memeo R, Conticchio M, Deshayes E, et al. Optimization of the future remnant liver: review of the current strategies in Europe. Hepatobiliary Surg Nutr, 2021, 10(3): 350-363.
4. Dixon M, Cruz J, Sarwani N, et al. The future liver remnant : definition, evaluation, and management. Am Surg, 2021, 87(2): 276-286.
5. Zhao HT, Cai JQ. Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. World J Gastroenterol, 2021, 27(47): 8069-8080.
6. 孙惠川, 沈英皓, 李小龙. 肝脏储备功能与肝癌术式选择. 中国实用外科杂志, 2018, 38(4): 473-476.
7. Saxena R, Theise ND, Crawford JM. Microanatomy of the human liver-exploring the hidden interfaces. Hepatology, 1999, 30(6): 1339-1346.
8. Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol, 2021, 18(1): 40-55.
9. Preziosi ME, Monga SP. Update on the mechanisms of liver regeneration. Semin Liver Dis, 2017, 37(2): 141-151.
10. 包胜娴. 原发性肝癌ALPPS- Ⅰ围术期肝脏血流动力学变化及其与剩余肝体积再生关系初步研究 . 南宁: 广西医科大学, 2023.
11. Kawaguchi Y, Lillemoe HA, Vauthey JN. Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy. J Surg Oncol, 2019, 119(5): 594-603.
12. 林伟鸿, 李凯. 肝切除术前肝脏储备功能评估方式的新进展. 中华外科杂志, 2021, 59(5): 392-396.
13. 王荣福, 庞小溪, 刘敏, 等. ^99mTc-GSA肝受体显像在肝功能评估临床研究应用及进展. 世界华人消化杂志, 2017, 25(21): 1903-1909.
14. Gavriilidis P, Edwin B, Pelanis E, et al. Navigated liver surgery: State of the art and future perspectives. Hepatobiliary Pancreat Dis Int, 2022, 21(3): 226-233.
15. Kim D, Cornman-Homonoff J, Madoff DC. Preparing for liver surgery with “Alphabet Soup”: PVE, ALPPS, TAE-PVE, LVD and RL. Hepatobiliary Surg Nutr, 2020, 9(2): 136-151.
16. 陈乾, 林慧敏, 严福华. 磁共振成像评估肝功能储备的研究进展. 诊断学理论与实践, 2023, 22(2): 190-196.
17. Poetter-Lang S, Bastati N, Messner A, et al. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom Radiol (NY), 2020, 45(11): 3532-3544.
18. Rous P, Larimore LD. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med, 1920, 31(5): 609-632.
19. Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg, 1986, 10(5): 803-808.
20. Vaupel P, Multhoff G. Blood supply and oxygenation status of the liver: from physiology to malignancy. Adv Exp Med Biol, 2022, 1395: 263-267.
21. 郑本波, 黄文. 术前经皮选择性门静脉栓塞术在肝胆肿瘤的应用体会. 肝胆外科杂志, 2021, 29(1): 46-48.
22. Isfordink CJ, Samim M, Braat MNGJA, et al. Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant: A systematic review and meta-analysis. Surg Oncol, 2017, 26(3): 257-267.
23. Brüning R, Schneider M, Tiede M, et al. Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales. CVIR Endovasc, 2021, 4(1): 41.
24. Palavecino M, Chun YS, Madoff DC, et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery, 2009, 145(4): 399-405.
25. Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg, 2000, 232(5): 665-672.
26. Wakabayashi H, Ishimura K, Okano K, et al. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer, 2001, 92(9): 2384-2390.
27. Glantzounis GK, Tokidis E, Basourakos SP, et al. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol, 2017, 43(1): 32-41.
28. 赵文超, 吴印涛, 杨英祥, 等. 肝动脉插管化疗栓塞联合选择性门静脉栓塞后手术切除治疗大肝癌的安全性和有效性观察. 中华肝胆外科杂志, 2021, 27(3): 164-168.
29. Kudo M, Ueshima K, Chan S, et al. Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study. Cancers (Basel), 2019, 11(8): 1084.
30. 徐彬, 李小龙, 朱小东, 等. 在接受仑伐替尼联合PD-1抗体治疗的不可切除肝细胞癌患者肝切除术前行门静脉栓塞术的研究. 中华肝胆外科杂志, 2022, 28(1): 21-27.
31. Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg, 2009, 249(4): 608-616.
32. Munene G, Parker RD, Larrigan J, et al. Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases. World J Surg Oncol, 2013, 11: 134.
33. Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol, 2016, 26(12): 4259-4267.
34. 刘畅, 张晓赟, 金谌, 等. 肝静脉系统栓堵术在第二阶段根治性肝癌切除术中的应用. 中国普外基础与临床杂志, 2019, 26(7): 841-846.
35. 王明宇, 梁英健, 尹兵, 等. 肝静脉剥夺术—残余肝脏不足时手术新思路. 中国实用外科杂志, 2020, 40(1): 102-105.
36. Schadde E, Guiu B, Deal R, et al. Simultaneous hepatic and portal vein ligation induces rapid liver hypertrophy: A study in pigs. Surgery, 2019, 165(3): 525-533.
37. Ko GY, Hwang S, Sung KB, et al. Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant. J Hepatobiliary Pancreat Sci, 2010, 17(4): 410-412.
38. 侯昌龙, 王继洲, 宋瑞鹏, 等. 术前肝静脉剥夺术同期联合精准肝动脉化疗栓塞在原发性大肝癌二期切除中应用价值研究. 中国实用外科杂志, 2022, 42(6): 667-671.
39. Cassese G, Troisi RI, Khayat S, et al. Liver venous deprivation versus associating liver partition and portal vein ligation for staged hepatectomy for colo-rectal liver metastases: a comparison of early and late kinetic growth rates, and perioperative and oncological outcomes. Surg Oncol, 2022, 43: 101812.
40. Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy? A retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
41. Girard E, Trilling B, Chirica M. Comment on: liver venous deprivation (LVD) or associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)? A retrospective multicentric study. Hepatobiliary Surg Nutr, 2021, 10(5): 675-677.
42. Guiu B, Quenet F, Panaro F, et al. Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes. Hepatobiliary Surg Nutr, 2020, 9(5): 564-576.
43. Gavriilidis P, Marangoni G, Ahmad J, et al. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis. Hepatobiliary Pancreat Dis Int, 2023, 22(3): 221-227.
44. Panaro F, Giannone F, Riviere B, et al. Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr, 2019, 8(4): 329-337.
45. Böning G, Fehrenbach U, Auer TA, et al. Liver venous deprivation (LVD) versus portal vein embolization (PVE) alone prior to extended hepatectomy: A matched pair analysis. Cardiovasc Intervent Radiol, 2022, 45(7): 950-957.
46. 高洁, 刘晓明, 周文华, 等. ⁹⁰Y微球的研发现状与应用研究. 同位素, 2022, 35(3): 189-199.
47. Jakobs TF, Saleem S, Atassi B, et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with ⁹⁰Yttrium microspheres. Dig Dis Sci, 2008, 53(9): 2556-2563.
48. Teo JY, Allen JC, Ng DC, et al. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with ⁹⁰Y. HPB (Oxford), 2016, 18(1): 7-12.
49. Garlipp B, de Baere T, Damm R, et al. Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. Hepatology, 2014, 59(5): 1864-1873.
50. Teo JY, Goh BK. Contra-lateral liver lobe hypertrophy after unilobar ⁹⁰Y radioembolization: an alternative to portal vein embolization? World J Gastroenterol, 2015, 21(11): 3170-3173.
51. Birgin E, Rasbach E, Seyfried S, et al. Contralateral liver hypertrophy and oncological outcome following radioembolization with ⁹⁰Y-microspheres: A systematic review. Cancers (Basel), 2020, 12(2): 294.
52. Najafi A, Binkert CA. Transarterial radioembolization to impact liver volumetry: when and how. Cardiovasc Intervent Radiol, 2022, 45(11): 1646-1650.
53. Garlipp B, Gibbs P, Van Hazel GA, et al. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial. Br J Surg, 2019, 106(13): 1837-1846.
54. Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg, 2012, 255(3): 405-414.
55. 周俭, 王征, 孙健, 等. 联合肝脏离断和门静脉结扎的二步肝切除术. 中华消化外科杂志, 2013, 12(7): 485-489.
56. 李世思, 郭志唐, 陈章彬, 等. ALPPS治疗肝脏肿瘤的研究进展. 肝胆胰外科杂志, 2021, 33(4): 253-257.
57. 刘允怡, 刘晓欣. 对“联合肝脏离断和门静脉结扎的二步肝切除术”的述评. 中华消化外科杂志, 2013, 12(7): 481-484.
58. 杨奎, 陈拥军. 联合肝脏离断和门静脉结扎二步肝切除术的热点与争议. 中华普通外科杂志, 2018, 33(2): 172-175.
59. Sparrelid E, Hasselgren K, Røsok BI, et al. How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue possibility. Hepatobiliary Surg Nutr, 2021, 10(1): 1-8.
60. 王征, 樊嘉, 周俭. ALPPS在肝脏外科的应用前景. 肝胆外科杂志, 2015, 23(1): 1-2.
61. 蔡涵晖, 胡智明, 杨鸿国. 门静脉栓塞术在计划性肝切除中的临床应用. 中华普通外科杂志, 2019, 34(2): 184-186.
62. 彭驰涵, 李川, 文天夫, 等. 原发性肝癌行ALPPS的适应证与禁忌证初探(附15例报道). 中国普外基础与临床杂志, 2015, 22(10): 1183-1186.
63. 陈伟, 梁力建. 联合肝脏离断和门静脉结扎的二步肝切除术在肝脏肿瘤治疗中的应用. 中华普通外科学文献(电子版), 2014, 8(3): 237-240.
64. 文天夫. ALPPS在肝细胞癌治疗中的地位. 中国普外基础与临床杂志, 2016, 23(1): 1-4.
65. Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg, 2015, 261(4): e90-e92.
66. Khajeh E, Ramouz A, Dooghaie Moghadam A, et al. Efficacy of technical modifications to the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure: A systematic review and meta-analysis. Ann Surg Open, 2022, 3(4): e221.
67. 闫加艳, 杨欣荣, 周俭. 联合肝脏分隔和门静脉结扎的二步肝切除术临床与基础研究进展. 中国普通外科杂志, 2023, 32(7): 967-976.
68. Gringeri E, Boetto R, D’Amico FE, et al. Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach. Ann Surg, 2015, 261(2): e42-e43.
69. 首志雄, 郑达武, 梁泳荣, 等. 腹腔镜辅助微波消融后行ALPPS治疗原发性肝癌的临床疗效观察. 中国普外基础与临床杂志, 2023, 30(8): 939-943.
70. 徐邦浩, 蓝祝晶, 朱海, 等. 联合肝实质分隔和门静脉结扎的二步肝切除术式演变进展. 中国普外基础与临床杂志, 2023, 30(7): 870-876.
71. 周承汇, 罗慧, 李嘉荣, 等. 腹腔镜辅助与开腹ALPPS治疗肝癌的近期疗效比较. 中国普通外科杂志, 2019, 28(3): 366-370.

Previous Article
Mechanism of immune checkpoint inhibitors related adverse events
Next Article
Diagnosis and treatment of 131 adult patients with bronchopulmonary sequestration: A retrospective analysis

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Current status and research progress of surgical-induced liver volume hyperplasia

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content